Skip to main content

Animations

MJFF Publications

3841 - 3850 of 6078 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • OPEN
    Title: [18F]Florbetapir PET/MR imaging to assess demyelination in multiple sclerosis
    Journal Name: European Journal of Nuclear Medicine and Molecular Imaging
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00259-019-04533-y
    Citation Count: 27
  • OPEN
    Title: Genetic architecture of subcortical brain structures in 38,851 individuals
    Journal Name: Nature Genetics
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41588-019-0511-y
    Citation Count: 253
  • OPEN
    Title: A novel approach to study markers of dopamine signaling in peripheral immune cells
    Journal Name: Journal of Immunological Methods
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jim.2019.112686
    Citation Count: 21
  • OPEN
    Title: Membrane association but not identity is required for LRRK2 activation and phosphorylation of Rab GTPases
    Journal Name: Journal of Cell Biology
    Publisher: Rockefeller University Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-sa
    DOI - Digital Object Identifier: 10.1083/jcb.201902184
    Citation Count: 101
  • OPEN
    Title: Neuropsychological Test Performances and Depression in Early-Stage De Novo Parkinson’s Disease
    Journal Name: Archives of Clinical Neuropsychology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/arclin/acz067
    Citation Count: 5
  • OPEN
    Title: A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson’s disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aau6870
    Citation Count: 94
  • OPEN
    Title: Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104623
    Citation Count: 74
  • OPEN
    Title: Are the International Parkinson disease and Movement Disorder Society progressive supranuclear palsy (IPMDS-PSP) diagnostic criteria accurate enough to differentiate common PSP phenotypes?
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: publisher-specific-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.10.012
    Citation Count: 25
  • OPEN
    Title: LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2019.104626
    Citation Count: 84
  • OPEN
    Title: Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0223621
    Citation Count: 14
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.